Alpha 2.0
Login Register
» Authors » P J S M Kerstens

P J S M Kerstens

Explore the profile of P J S M Kerstens including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 1057
Followers 0
Related Specialties
Rheumatology
Orthopedics
Physiology
Top 10 Co-Authors
C F Allaart
B A C Dijkmans
T W J Huizinga
W F Lems
Y P M Goekoop-Ruiterman
N B Klarenbeek
J K de Vries-Bouwstra
K H Han
F C Breedveld
A E Voskuyl
Published In
Ann Rheum Dis
Arthritis Rheum
Rheumatology (Oxford)
Arthritis Care Res (Hoboken)
Clin Rheumatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial
Lucassen M, ter Wee M, den Uyl D, Konijn N, Nurmohamed M, Voskuyl A, et al.
Osteoporos Int . 2021 Jan; 32(7):1441-1449. PMID: 33464392
Purpose: To assess changes in bone mineral density (BMD) after 4 years in early rheumatoid arthritis (RA) patients initially treated with COBRA-light or COBRA therapy. Methods: In a 1 year,...
2.
Age affects joint space narrowing in patients with early active rheumatoid arthritis
Matthijssen X, Akdemir G, Markusse I, Stijnen T, Riyazi N, Han K, et al.
RMD Open . 2016 Nov; 2(2):e000338. PMID: 27843577
Background: Joint space narrowing (JSN) in rheumatoid arthritis (RA) may be a manifestation of (primary) osteoarthritis becoming more prominent with age. We investigated the severity and predictors of JSN progression...
3.
Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission
Akdemir G, Markusse I, Goekoop-Ruiterman Y, Steup-Beekman G, Grillet B, Kerstens P, et al.
Clin Rheumatol . 2016 Sep; 36(2):317-326. PMID: 27680540
To compare rheumatologists' adherence to treatment protocols for rheumatoid arthritis (RA) targeted at Disease Activity Score (DAS) ≤2.4 or <1.6. The BeSt-study enrolled 508 early RA (1987) patients targeted at...
4.
Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation
Markusse I, Dirven L, Han K, Ronday H, de Sonnaville P, Kerstens P, et al.
Arthritis Care Res (Hoboken) . 2015 Aug; 68(4):446-53. PMID: 26239288
Objective: To evaluate rheumatologists' adherence to a low Disease Activity Score (DAS)-steered treat-to-target (T2T) strategy in treatment of patients with rheumatoid arthritis (RA) and to assess associated conditions. Methods: Data...
5.
Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients
Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han K, et al.
Arthritis Care Res (Hoboken) . 2013 Feb; 65(8):1235-42. PMID: 23408767
Objective: To assess the association between high body mass index (BMI) and treatment response in recent-onset rheumatoid arthritis. Methods: In the Behandelstrategieën voor Reumatoide Artritis (Treatment Strategies for Rheumatoid Arthritis)...
6.
Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy
Dirven L, Klarenbeek N, van den Broek M, van Groenendael J, de Sonnaville P, Kerstens P, et al.
Clin Rheumatol . 2012 Dec; 32(5):585-90. PMID: 23224330
Objective: To determine incidence of increased levels of alanine transferase (ALT) >2× upper limit of normal (ULN) in patients receiving methotrexate (MTX), treated according to a dynamic strategy, and to...
7.
Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis
Dirven L, van den Broek M, van Groenendael J, de Beus W, Kerstens P, Huizinga T, et al.
BMC Musculoskelet Disord . 2012 Jul; 13:125. PMID: 22824097
Objective: To determine the prevalence of vertebral fractures (VFs) after 5 years of disease activity score (DAS)-steered treatment in patients with early rheumatoid arthritis (RA) and to investigate the association...
8.
Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up
van den Broek M, Dirven L, de Vries-Bouwstra J, Dehpoor A, Goekoop-Ruiterman Y, Gerards A, et al.
Ann Rheum Dis . 2012 Apr; 71(9):1530-3. PMID: 22532630
Objective: Several prediction models for rapid radiological progression (RRP) in the first year of rheumatoid arthritis have been designed to aid rheumatologists in their choice of initial treatment. The association...
9.
The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study
van den Broek M, Dirven L, Klarenbeek N, Molenaar T, Han K, Kerstens P, et al.
Ann Rheum Dis . 2011 Nov; 71(2):245-8. PMID: 22110122
Objective: Anticitrullinated protein antibodies (ACPAs) are suggested to identify different subsets of patients with rheumatoid arthritis (RA). The authors compared the clinical and radiological responses to Disease Activity Score (DAS)-steered...
10.
Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression
Dirven L, Visser K, Klarenbeek N, Ewals J, Han K, Peeters A, et al.
Scand J Rheumatol . 2011 Nov; 41(1):15-9. PMID: 22103436
Objective: Personalized treatment depends on the treatment goals. Current prediction models to guide initial treatment choices focus on radiological damage progression. However, for some patients this outcome is less relevant,...